Literature DB >> 8847526

Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation.

X F Yu1, Z Matsuda, Q C Yu, T H Lee, M Essex.   

Abstract

Lentiviral Gag polyproteins have a proline-rich protein, p6, at their C terminus. There are conflicting reports about the function of p6 in virus release. In the present work, mutants that affect p6 of human immunodeficiency virus type 1 (HIV-1) Gag polyprotein were constructed and analysed. None of the mutants prevented virus release completely; however, detachment of budding particles was less efficient as evidenced by electron microscopy. Virions of the p6 truncation mutant B2TAA had a significantly reduced number of Pol proteins (p66, p51 and p34) and an increased amount of incompletely processed Gag proteins compared with the parental virus. A mutation that altered the cleavage site between p6 and p1 did not significantly affect virus assembly, virus release or protein processing with the exception of cleavage between p6 and p1. However, virions of this mutant (B2P6C) exhibited irregular-shaped core structures that were distinct from the cone-shaped core structure seen in the parental virion. B2P6C mutant virus was non-infectious in CD4+ T cells. These results suggest that mutations in p6 affect efficient detachment of budding particles from the cell surface. Proper cleavage between p6 and p1 may be critical for the formation of the distinctive cone-shaped core structure of HIV-1 virions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847526     DOI: 10.1099/0022-1317-76-12-3171

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.

Authors:  M A Accola; B Strack; H G Göttlinger
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 2.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

3.  Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein.

Authors:  S Peters; M Muñoz; S Yerly; V Sanchez-Merino; C Lopez-Galindez; L Perrin; B Larder; D Cmarko; S Fakan; P Meylan; A Telenti
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.

Authors:  Dimiter G Demirov; Jan M Orenstein; Eric O Freed
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes.

Authors:  Y M Lee; B Liu; X F Yu
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.

Authors:  Feng Li; Chaoping Chen; Bridget A Puffer; Ronald C Montelaro
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Characterization of RNA elements that regulate gag-pol ribosomal frameshifting in equine infectious anemia virus.

Authors:  Chaoping Chen; Ronald C Montelaro
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Basal budding and replication of the murine leukemia virus are independent of the gag L domains.

Authors:  Yosef Sabo; Nihay Laham-Karam; Eran Bacharach
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.

Authors:  Daniel Melamed; Michal Mark-Danieli; Michal Kenan-Eichler; Osnat Kraus; Asher Castiel; Nihay Laham; Tal Pupko; Fabian Glaser; Nir Ben-Tal; Eran Bacharach
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions.

Authors:  M Dettenhofer; X F Yu
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.